Trial intelligence / Profile preview

Palatability of New Paediatric Valacyclovir Formulation

NCT01682109Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Sep 2012
Primary completion
Mar 2016
Modality
Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of valaciclovir in varicella zoster virus infection, herpes simplex virus infection, sponsored by Radboud University Medical Center. Started Sep 2012; status: completed.

02

Drugs

valaciclovir
03

Conditions

varicella zoster virus infectionherpes simplex virus infection

Beyond the preview

Go deeper on NCT01682109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01682109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call